NCT06131619

Brief Summary

The purpose of this study is to evaluate the usefulness of Dynamic Loewenstein's Occupational Therapy and Cognitive Assessment Scale for Geriatrics (DLOTCA-G) in parkinson patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 5, 2022

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

November 9, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 14, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 24, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 17, 2024

Completed
Last Updated

March 20, 2024

Status Verified

March 1, 2024

Enrollment Period

1.6 years

First QC Date

November 9, 2023

Last Update Submit

March 19, 2024

Conditions

Keywords

Parkinson DiseaseDLOTCA-G

Outcome Measures

Primary Outcomes (1)

  • Dynamic Lowenstein Occupational Therapy Cognitive Assessment-Geriatric Version

    The Dynamic Lowenstein Occupational Therapy Cognitive Assessment is an occupational performance measurement battery designed to assess basic cognitive skills and visual perception in adults with neurological deficits. Consists 8 subtests: orientation, awareness, visual perception, spatial perception, praxis, visuomotor construction and thinking operations and memory. All subtests of DLOTCA-G are scored between 1 - 4 points. And higher scores indicate better cognitive performance. There is no cut-off value for Parkinson's patients.

    Baseline (First assessment)

Secondary Outcomes (1)

  • Mini Mental State Examination

    Baseline (First assessment)

Study Arms (3)

Experimental

Parkinson's disease patients with cognitive impairment

Other: assesment of cognitive parameters with DLOTCA-G

Active Comparator

Parkinson's disease patients without cognıtıve impairment

Other: assesment of cognitive parameters with DLOTCA-G

other

Health geriatric persons

Other: assesment of cognitive parameters with DLOTCA-G

Interventions

All three groups were evaluated once with the DLOTCA-G, a cognitive assessment battery.

Active ComparatorExperimentalother

Eligibility Criteria

Age65 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Parkinson's dissease patients

Inclusıon Criteria * Parkinson's patients aged 65 years and older with and without cognitive impairment (60 patients) and healthy control patients (30 patients) * Hoehnn Yahr Staging between 1 and 2.5 in patients with Parkinson's diseas * Confirmed by brain MRI from patients without vascular dementia who routinely attend the Parkinson's follow-up outpatient clinic * At least primary school graduates * In patients with Parkinson's dissease patients with cognitive impairment, MMSE below 20 in primary school education level; below 24 in secondary, high school and university education level * In patients with Parkinson's disease without cognitive impairment, MMSE 20 and above in primary school education level; 24 and above in secondary, high school and university education level Exclusıon Criteria * Preexisting cognitive impairment * Psychiatric disorders such as psychotic disorders, mood disorders, alcohol or drug abuse * Severe language dysfunction and/or bilateral limb motor dysfunction and inability to participate in clinical psychology tests, severe visual and/or auditory impairments * Patients with significant cerebral atrophy or neurological vascular lesions * The Geriatric Depression Scale was administered to all participants, and participants with a total score of 13 or more out of 30 points were excluded from the study.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Kütahya Health Sciences University

Kütahya, 430020, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assoc.prof dr

Study Record Dates

First Submitted

November 9, 2023

First Posted

November 14, 2023

Study Start

June 5, 2022

Primary Completion

January 24, 2024

Study Completion

March 17, 2024

Last Updated

March 20, 2024

Record last verified: 2024-03

Locations